IP Library Granted Patent US 8,765,415
Granted Patent B2
US 8,765,415 · App. 13/510,372 · Granted Jul 1, 2014

Methods for enhanced protein production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,415
App. No.
13/510,372
Granted
Jul 1, 2014
Kind
B2
Abstract

The present invention provides a method of increasing protein production in a cell culture by growing cells that produce the protein (e.g., the growth phase) in a perfusion cell culture to a high cell density (i.e., at least above about 40×10 6 cells/N mL) and then switching to a protein production phase, wherein the cells are cultured in a fed-batch cell culture. The present invention further provides a method for clarifying a protein from a cell culture by adjusting the pH of the cell culture to below neutral pH (i.e., below a pH of 7) and settling the cell culture, such that the cell culture separates to form a supernatant layer and a cell-bed layer, wherein the protein is in the supernatant layer.

Claims (15)

1. A method of increasing production of a protein in a cell culture, comprising:

a) growing cells which produce the protein in a perfusion cell culture to a cell density of at least about 100×10 6 cells/mL; and

b) transferring the cells to a fed-batch cell culture, such that the cells enter a production phase, thereby increasing production of a protein in the cells.

2. The method of claim 1 , wherein the cells are grown in the perfusion cell culture to a cell density of between about 100×10 6 cells/mL and 200×10 6 cells/mL.

3. The method of claim 1 , wherein the cells are animal cells.

4. The method of claim 1 , wherein the protein is an antibody.

5. The method of claim 1 , wherein the protein is selected from the group consisting of enzymes, receptors, fusion proteins, cytokines, regulatory factors, hormones, antigen-binding agents, therapeutic proteins, and diagnostic proteins.

6. The method of claim 1 , wherein the perfusion cell culture and fed-batch cell culture are grown in a single bioreactor.

7. The method of claim 1 , wherein the perfusion cell culture and fed-batch cell culture are grown in separate bioreactors.

8. The method of claim 1 , wherein the fed-batch cell culture is grown in multiple bioreactors.

9. The method of claim 1 , further comprising collecting the protein from the fed-batch cell culture and not the perfusion cell culture.

10. The method of claim 1 , further comprising collecting the protein from both the perfusion culture and the fed-batch cell culture.

11. The method of claim 1 , wherein the cells are Chinese Hamster Ovary (CHO) cells.

12. The method of claim 4 , wherein the antibody is a monoclonal antibody.

13. The method of claim 12 , wherein the monoclonal antibody is selected from the group consisting of a human, humanized and chimeric antibody.

Assignments (2)
MERGER Recorded Mar 19, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035226/0690 →
MERGER Recorded Jun 13, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 030603/0924 →